• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Nu Skin Expands and Repackages ageLOC® Tru Face® Line, Setting a New Standard for Sustainable Skincare

    6/25/25 4:05:00 PM ET
    $NUS
    Other Pharmaceuticals
    Health Care
    Get the next $NUS alert in real time by email

    Nu Skin Enterprises Inc. (NYSE:NUS), a global beauty and wellness company, is breathing new life into its iconic ageLOC® Tru Face® line with a relaunch that merges high-performance skincare with planet-friendly innovation. The refreshed line now features upgraded, more sustainable packaging designed to reduce environmental impact — cutting down on waste, lowering carbon emissions and embracing a refillable system that puts conscious beauty front and center.

    This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250625017051/en/

    The Tru Face skincare line from Nu Skin

    The Tru Face skincare line from Nu Skin

    This repackaging initiative is part of the brand's broader sustainability goals. By the end of 2025, Nu Skin anticipates that based on estimated global sales, its refill packaging systems will save 515,000 pounds (257.5 tons) of glass and plastic, while also eliminating 572 tons of emissions each year, compared to its prior single-use glass packaging. These innovative design choices reflect a growing commitment to circular economy principles and conscious consumerism.

    "Our relaunch of Tru Face reflects Nu Skin's deep commitment to both scientific innovation and environmental stewardship," said Ryan Napierski, Nu Skin president and CEO. "We're proud to deliver effective, clinically backed solutions while empowering our customers to make more sustainable choices every day."

    The Tru Face collection delivers visible firming, smoothing and contouring benefits now paired with an environmentally conscious design to reflect Nu Skin's ongoing commitment to eco-conscious luxury. Key highlights of the upgraded packaging include refillable systems and packaging made from recycled materials.

    • ageLOC® Tru Face® Transforming Gel Cream: This clinically proven gel cream targets the sources of aging while deeply hydrating and smoothing skin. In just two weeks, 100% of users reported more hydrated skin with improvements in radiance, softness and reduced lines.
    • ageLOC® Tru Face® Refining Toner: A new addition to the ageLOC® Tru Face® line, this toner gently exfoliates while boosting hydration. In four weeks, users in our in-house clinical study saw up to 47% improvement in tone evenness and 45% boost in hydration.
    • ageLOC® Tru Face® Line Corrector: Now made with 35% recycled material.
    • ageLOC® Tru Face® Essence Ultra Rich Cream: Now available in a luxury refillable cartridge system with a durable outer shell and recyclable inner cartridge, designed to reduce single-use plastic and extend the product lifecycle.
    • ageLOC® Tru Face® Peptide Retinol Complex: Formulated with AI-enhanced, clinically proven peptide technology, this facial serum delivers rapid results in a gentle formula. Packaged in a mono-material pump system with a refill cartridge made from 100% recycled materials designed to minimize carbon emissions and waste.
    • ageLOC® Tru Face® Future Serum: Uses a refill system that reduces packaging waste by 72% per refill and an estimated annual packaging waste by 53%; the inner bottle is made from 100% recycled material, avoiding an estimated 56 tons of carbon emissions per year compared to our prior packaging based on projected global annual sales.
    • ageLOC® Tru Face® Essence Ultra (TFEU): A serum featuring powerful dissolvable beads housed in a reusable jar. The refill pouch is only 3.4 grams (31 times lighter than the glass jar) and has reduced packaging material use by 96.8%. The use of TFEU refills save an estimated 11.8 tons of glass annually, with beads that fully dissolve in water to eliminate waste.
    • ageLOC® Tru Face® Radiant Day: A lightweight daily SPF lotion that now uses 24% recycled materials.

    The Tru Face® line is now available at www.nuskin.com. New packaging updates will be released over the next several months.

    About Nu Skin Enterprises

    The Nu Skin Enterprises Inc. (NYSE:NUS) family of companies includes Nu Skin and Rhyz Inc. Nu Skin is an integrated beauty and wellness company, powered by a dynamic affiliate opportunity platform, which operates in nearly 50 markets worldwide. Backed by 40 years of scientific research, the company's products help people look, feel and live their best with brands including Nu Skin® personal care, Pharmanex® nutrition and ageLOC® anti-aging, which includes an award-winning line of beauty device systems. Formed in 2018, Rhyz is a synergistic ecosystem of consumer, technology and manufacturing companies focused on innovation within the beauty, wellness and lifestyle categories.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250625017051/en/

    Media: [email protected], (801) 345-6397

    Investors: [email protected], (801) 345-3577

    Get the next $NUS alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $NUS

    DatePrice TargetRatingAnalyst
    1/31/2023$43.00 → $39.00Buy → Hold
    Jefferies
    2/17/2022$47.00 → $50.00Neutral
    DA Davidson
    11/24/2021$43.00 → $49.00Neutral
    Citigroup
    10/6/2021$61.00 → $47.00Neutral
    DA Davidson
    More analyst ratings

    $NUS
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Nu Skin Expands and Repackages ageLOC® Tru Face® Line, Setting a New Standard for Sustainable Skincare

      Nu Skin Enterprises Inc. (NYSE:NUS), a global beauty and wellness company, is breathing new life into its iconic ageLOC® Tru Face® line with a relaunch that merges high-performance skincare with planet-friendly innovation. The refreshed line now features upgraded, more sustainable packaging designed to reduce environmental impact — cutting down on waste, lowering carbon emissions and embracing a refillable system that puts conscious beauty front and center. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250625017051/en/The Tru Face skincare line from Nu Skin This repackaging initiative is part of the brand's broader sustainabili

      6/25/25 4:05:00 PM ET
      $NUS
      Other Pharmaceuticals
      Health Care
    • Nu Skin Enterprises Appoints James Winett to Board of Directors

      Nu Skin Enterprises (US:NYSE) today announced the appointment of James Winett, a managing member of SIZE Advisory Group, to the company's board of directors. He was elected by shareholders at the annual shareholder meeting for Nu Skin Enterprises. "Jim adds extensive expertise in strategic planning, operations and finance from his many years of consulting experience," said Steven J. Lund, executive chairman of the board. "He will also be an asset to our Rhyz businesses with his background in corporate transactions and advising small businesses and start-ups. We welcome Jim to the board and look forward to tapping into his insights and experience." Winett is a managing member of SIZE Adv

      6/2/25 12:19:00 PM ET
      $NUS
      Other Pharmaceuticals
      Health Care
    • Nu Skin Enterprises Reports First Quarter Revenue at High End of Guidance

      Nu Skin Enterprises Inc. (NYSE:NUS) today announced first quarter revenue at the high end of its guidance range. Executive Summary Q1 2025 vs. Prior-year Quarter Revenue $364.5 million; (12.7)% (3.0)% FX impact or $(12.3) million Earnings Per Share (EPS) $2.14 or $0.23 excluding Mavely gain and other charges compared to $(0.01) or $0.09 excluding restructuring charges Customers 776,712; (11)% Paid Affiliates 131,518; (15)% Sales Leaders 31,036; (20)% "We are pleased to achieve revenue at the high end of our guidance range and exceed our adjusted earnings forecast to start out the year," said Ryan Napierski, Nu Skin president and CEO. "We drove

      5/8/25 4:06:00 PM ET
      $NUS
      Other Pharmaceuticals
      Health Care

    $NUS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Woodbury Edwina D was granted 13 shares, increasing direct ownership by 0.03% to 42,960 units (SEC Form 4)

      4 - NU SKIN ENTERPRISES, INC. (0001021561) (Issuer)

      6/12/25 5:32:53 PM ET
      $NUS
      Other Pharmaceuticals
      Health Care
    • Director Campbell Daniel W was granted 18,008 shares, increasing direct ownership by 60% to 48,262 units (SEC Form 4)

      4 - NU SKIN ENTERPRISES, INC. (0001021561) (Issuer)

      6/3/25 5:50:59 PM ET
      $NUS
      Other Pharmaceuticals
      Health Care
    • Director Nathanson Laura was granted 18,008 shares, increasing direct ownership by 83% to 39,638 units (SEC Form 4)

      4 - NU SKIN ENTERPRISES, INC. (0001021561) (Issuer)

      6/3/25 5:49:32 PM ET
      $NUS
      Other Pharmaceuticals
      Health Care

    $NUS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Nu Skin downgraded by Jefferies with a new price target

      Jefferies downgraded Nu Skin from Buy to Hold and set a new price target of $39.00 from $43.00 previously

      1/31/23 6:17:27 AM ET
      $NUS
      Other Pharmaceuticals
      Health Care
    • DA Davidson reiterated coverage on Nu Skin Enterprises with a new price target

      DA Davidson reiterated coverage of Nu Skin Enterprises with a rating of Neutral and set a new price target of $50.00 from $47.00 previously

      2/17/22 4:46:52 AM ET
      $NUS
      Other Pharmaceuticals
      Health Care
    • Citigroup reiterated coverage on Nu Skin Enterprises with a new price target

      Citigroup reiterated coverage of Nu Skin Enterprises with a rating of Neutral and set a new price target of $49.00 from $43.00 previously

      11/24/21 11:03:39 AM ET
      $NUS
      Other Pharmaceuticals
      Health Care

    $NUS
    SEC Filings

    See more
    • SEC Form S-8 filed by Nu Skin Enterprises Inc.

      S-8 - NU SKIN ENTERPRISES, INC. (0001021561) (Filer)

      6/2/25 4:25:09 PM ET
      $NUS
      Other Pharmaceuticals
      Health Care
    • Nu Skin Enterprises Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

      8-K - NU SKIN ENTERPRISES, INC. (0001021561) (Filer)

      5/30/25 4:05:53 PM ET
      $NUS
      Other Pharmaceuticals
      Health Care
    • SEC Form SD filed by Nu Skin Enterprises Inc.

      SD - NU SKIN ENTERPRISES, INC. (0001021561) (Filer)

      5/27/25 6:01:26 AM ET
      $NUS
      Other Pharmaceuticals
      Health Care

    $NUS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Product Officer Hatchett Steven Keith bought $49,010 worth of shares (6,500 units at $7.54), increasing direct ownership by 4% to 162,065 units (SEC Form 4)

      4 - NU SKIN ENTERPRISES, INC. (0001021561) (Issuer)

      5/28/25 6:26:44 PM ET
      $NUS
      Other Pharmaceuticals
      Health Care

    $NUS
    Leadership Updates

    Live Leadership Updates

    See more
    • Nu Skin Enterprises Appoints James Winett to Board of Directors

      Nu Skin Enterprises (US:NYSE) today announced the appointment of James Winett, a managing member of SIZE Advisory Group, to the company's board of directors. He was elected by shareholders at the annual shareholder meeting for Nu Skin Enterprises. "Jim adds extensive expertise in strategic planning, operations and finance from his many years of consulting experience," said Steven J. Lund, executive chairman of the board. "He will also be an asset to our Rhyz businesses with his background in corporate transactions and advising small businesses and start-ups. We welcome Jim to the board and look forward to tapping into his insights and experience." Winett is a managing member of SIZE Adv

      6/2/25 12:19:00 PM ET
      $NUS
      Other Pharmaceuticals
      Health Care
    • Nu Skin Enterprises Appoints Mark A. Zorko to Board of Directors

      Nu Skin Enterprises (NYSE:NUS) today announced the appointment of Mark A. Zorko, a principal with executive management association Brentwood Advisory Group, to the company's board of directors. The board also appointed Zorko to serve on its audit committee and the nominating and corporate governance committee. "Mark brings extensive C-level leadership experience with several global public companies, as well as more than 20 years of board-level experience," said Steven J. Lund, executive chairman of the board. "We welcome Mark to the board and look forward to leveraging his extensive business insights and experience." Zorko is a principal with Brentwood Advisory, an association he co-found

      9/12/24 4:05:00 PM ET
      $NUS
      Other Pharmaceuticals
      Health Care
    • Palantir Technologies, Dell Technologies, and Erie Indemnity Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600

      NEW YORK, Sept. 6, 2024 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, September 23, to coincide with the quarterly rebalance. The changes ensure each index is more representative of its market capitalization range. All companies being added to the S&P 500 are more representative of the large-cap market space, all companies being added to the S&P MidCap 400 are more representative of the mid-cap market space, and all companies being added to the S&P SmallCap 600 are more representative of the small-cap market space. The companies being removed from

      9/6/24 6:43:00 PM ET
      $AAL
      $ADMA
      $ADNT
      $AMCX
      Air Freight/Delivery Services
      Consumer Discretionary
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care

    $NUS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Nu Skin Enterprises Inc.

      SC 13G/A - NU SKIN ENTERPRISES, INC. (0001021561) (Subject)

      11/12/24 4:47:17 PM ET
      $NUS
      Other Pharmaceuticals
      Health Care
    • Amendment: SEC Form SC 13G/A filed by Nu Skin Enterprises Inc.

      SC 13G/A - NU SKIN ENTERPRISES, INC. (0001021561) (Subject)

      11/6/24 10:20:59 AM ET
      $NUS
      Other Pharmaceuticals
      Health Care
    • Amendment: SEC Form SC 13G/A filed by Nu Skin Enterprises Inc.

      SC 13G/A - NU SKIN ENTERPRISES, INC. (0001021561) (Subject)

      11/4/24 10:21:31 AM ET
      $NUS
      Other Pharmaceuticals
      Health Care

    $NUS
    Financials

    Live finance-specific insights

    See more
    • Nu Skin Enterprises Reports First Quarter Revenue at High End of Guidance

      Nu Skin Enterprises Inc. (NYSE:NUS) today announced first quarter revenue at the high end of its guidance range. Executive Summary Q1 2025 vs. Prior-year Quarter Revenue $364.5 million; (12.7)% (3.0)% FX impact or $(12.3) million Earnings Per Share (EPS) $2.14 or $0.23 excluding Mavely gain and other charges compared to $(0.01) or $0.09 excluding restructuring charges Customers 776,712; (11)% Paid Affiliates 131,518; (15)% Sales Leaders 31,036; (20)% "We are pleased to achieve revenue at the high end of our guidance range and exceed our adjusted earnings forecast to start out the year," said Ryan Napierski, Nu Skin president and CEO. "We drove

      5/8/25 4:06:00 PM ET
      $NUS
      Other Pharmaceuticals
      Health Care
    • Nu Skin Enterprises Announces Quarterly Dividend

      Nu Skin Enterprises, Inc. (NYSE:NUS) today announced its board of directors has declared a quarterly cash dividend of $0.06 per share, which will be paid on June 11, 2025, to shareholders of record on May 30, 2025. About Nu Skin Enterprises, Inc. The Nu Skin Enterprises Inc. (NYSE:NUS) family of companies includes Nu Skin and Rhyz Inc. Nu Skin is an integrated beauty and wellness company, powered by a dynamic affiliate opportunity platform, which operates in nearly 50 markets worldwide. Backed by 40 years of scientific research, the company's products help people look, feel and live their best with brands including Nu Skin® personal care, Pharmanex® nutrition and ageLOC® anti-aging, which

      5/8/25 4:05:00 PM ET
      $NUS
      Other Pharmaceuticals
      Health Care
    • Nu Skin Enterprises to Announce First Quarter 2025 Financial Results

      Nu Skin Enterprises, Inc. (NYSE:NUS) today announced it will release first quarter 2025 results after the market closes on Thursday, May 8. The Nu Skin management team will host a conference call with the investment community later that same day at 5 p.m. ET. During the call, management will discuss recent results and upcoming business initiatives. The webcast of the conference call, including the financial information presented, will be available on the investor relations page of the company's website at ir.nuskin.com. A replay of the webcast will be available at the same location through Thursday, May 22. About Nu Skin Enterprises Inc. The Nu Skin Enterprises Inc. (NYSE:NUS) family of

      4/2/25 4:15:00 PM ET
      $NUS
      Other Pharmaceuticals
      Health Care